Indian-Origin Professor's UK Firm Strikes Covid Vaccine Pact With India

An Indian-origin professor's Oxford-based company on Tuesday announced that its Indian partner, the Serum Institute of India (SIIPL), has begun trials of a novel virus-like particle (VLP) vaccine...